
KABILA Updates🩺
February 18, 2025 at 03:47 PM
Tirzepatide Approved for OSA!
FDA approves Tirzepatide for moderate-to-severe OSA in obese adults. Originally for Type 2 Diabetes & Obesity, it aids weight loss, improving OSA.
Precautions: Avoid in pregnancy, risk of thyroid cancer, AKI, pancreatitis.
